South Korea: SD Biosensor prices IPO at top of range to raise US$680m

Covid-19 test kit maker, SD Biosensor, priced its IPO at the top of the indicative price range, according to press reports. The 14.9 million shares were marketed in the range W45,000 to W52,000 to raise a total of W776.4bn (US$680m). The pricing gives the company an implied market cap of W5.28trn. Demand for the share sales…

You must be a HMI Subscriber to view this content.

Subscribe Now »